1 Independent draft report outcome This report has incurred Pfizer to react immediately, likely RAP valued more than 11.5C, otherwise the scheme vote will stay on track
2 The company considers the draft The more indifferent BOD shows, the more it reveals the conflict they are facing. They were asked to support the schemes before the voting, looks like that job is now finished, and they are not sure what to do next.
3 Pfizer decision If the valuation is below or close to 20c, it is not reasonable that Pfizer leave the game they started given their input, here they may raise the T/O. As the company said they are considering the draft, my guess is either Pfizer stopped the offer for some reason or changed to offer which request BOD step down
all imo
RAP Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held
